Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

4.13
+0.10002.48%
Pre-market: 4.130.00000.00%07:23 EDT
Volume:32.79M
Turnover:136.42M
Market Cap:2.21B
PE:-4.04
High:4.29
Open:4.09
Low:3.98
Close:4.03
52wk High:7.18
52wk Low:2.77
Shares:535.00M
Float Shares:522.33M
Volume Ratio:1.86
T/O Rate:6.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0219
EPS(LYR):-1.4410
ROE:-56.58%
ROA:-27.33%
PB:2.41
PE(LYR):-2.87

Loading ...

Dec 05, 2024

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer, Gibson Christopher, proposes to sell 20,000 shares, with a total value of approximately $142,400.
Dec 04, 2024

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS, INC.'s Officer Gibson Christopher proposes to sell 20000 Shares, with a total value of approximately $143,200.
Dec 03, 2024

Major Issues Report

Form 8-K - Current report
Nov 27, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 26, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 20, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 04, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities